Ranbaxy Laboratories’ OTC business division launches ‘Volini Duo’

12 Aug 2011 Evaluate

Ranbaxy Laboratories’ OTC business division-Ranbaxy  Global Consumer  Healthcare has launched  ‘Volini  Duo’, India’s first approved two in one  pain killer, a unique bi-layered Acetminophen tablet, specially formulated to give dual pain relief. The product has been introduced pan India.

‘Volini Duo’ has been developed by scientist at company’s state of art R&D centre in Gurgaon, using Metrix technology, which enables the regulated release of the medicine in the gastrointestinal tract. It is specifically effective for back and joint pains, which are primarily chronic in nature.

Volini Duo tablet marks the entry of Ranbaxy in the OTC oral pain reliever category. The OTC oral analgesics market in India is estimated to be Rs 700 crore and is growing annually at the rate of 10.5%.

Ranbaxy Laboratories is India's largest pharmaceutical company. The company has global presence in 49 countries and is ranked amongst top ten global generics companies. Ranbaxy has world-class manufacturing facilities in 11 countries namely Brazil, China, Ireland, India, Japan, Malaysia, Nigeria, Romania, South Africa, USA and Vietnam.

Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×